Lehne's Pharmacology for Nursing Care 10th Edition TEST BANK(Chapter 1-110).

Lehne's Pharmacology for Nursing Care 10th Edition TEST
BANK(Chapter 1-110).

Chapterno3:noDrugnoRegulation,noDevelopment,noNames,noandnoInfor
mationnoTestnoBank



MULTIPLEnoCHOICE

1. Anonursenoeducatornoisnoconductingnoanocontinuingnoeducationnoclassnoonnopharmacology.no
Tonoevaluatenothenolearningnoofnothenonursesnoinnothenoclass,nothenonursenoeducatornoasks,no
―Whichnodrugnonamenoisnoanogenericnodrugnoname?‖noWhichnoisnothenocorrectnoresponse?no
a.noAcetaminophen
b. Tylenol
c. Cipro
d. Motrin
ANS:noA
Acetaminophennoisnothenogenericnoname.noTylenol,noCipro,noandnoMotrinnoarenoallnotradenonames.

DIF:noCognitivenoLevel:noComprehension REF:noTableno3-
3:noThenoThreenoTypesnoofnoDrugnoNamesnoTOP:noNursingnoProcess:noDiagnosis
MSC:noNCLEXnoClientnoNeedsnoCategory:noPhysiologicnoIntegrity:noPharmacologicnoandnoParenteralnoThe
rapies

2. ThenoFDAnoAmendmentsnoActno(FDAAA)nowasnopassednoinno2007notonoaddressnowhichnoas
pectnoofnodrugnosafety?
a. Allowingnopharmaceuticalnocompaniesnotonoidentifynooff-
labelnousesnoofnomedicationsnoapprovednofornoothernouses
b. Evaluatingnodrugnosafetynoinformationnothatnoemergesnoafternoanodrugnohasnobeennoappr
ovednoandnoisnoinnouse
c. ExpeditingnothenoapprovalnoprocessnoofnothenoU.S.noFoodnoandnoDrugnoAdministration
no(FDA)nosonothatnoneedednodrugsnocannogetnotonomarketnomorenoquickly
d. Requiringnomanufacturersnotononotifynopatientsnobeforenoremovingnoanodrugnofromnothenomarket
ANS:noB
ThenoFDAAAnowasnopassednotonoenablenothenoFoodnoandnoDrugnoAdministrationnotonocontinuen
ooversightnoofnoanodrugnoafternograntingnoitnoapprovalnosonothatnochangesnoinnolabelingnocouldno
benomadenoasnonecessarynoandnopostmarketingnorisksnocouldnobenotrackednoandnoidentified.noAn
oprovisionnoofnothenoFDAnoModernizationnoActno(FDAMA),nopassednoinno1997,noallowsnodrugn
ocompaniesnotonopromotenotheirnoproductsnofornooff-
labelnousesnoasnolongnoasnotheynopromisenotonoconductnostudiesnotonosupportnotheirnoclaims.noRe
gulationsnotonopermitnoacceleratednoapprovalnoofnodrugsnofornolife-
threateningnodiseasesnowerenoadoptednoinno1992nobynothenoFDA.noThenorequirementnothatnodru
gnocompaniesnonotifynopatientsno6nomonthsnobeforenoremovingnoanodrugnofromnothenomarketnois
noanoprovisionnoofnothenoFDAMA.

,TestnoBanknoLehne'snoPharmacologynofornoNursingnoCare,no11thn
oEditionnobynoJacquelinenoBurchum,noLauranoRosenthalnoChapte

rno1-no112|CompletenoGuidenoA+
DIF:noCognitivenoLevel:noComprehension
REF:noLandmarknoDrugnoLegislat
ionnoTOP:noNursingnoProcess:noEvaluation
MSC:noNCLEXnoClientnoNeedsnoCategory:noPhysiologicnoIntegrity:noPharmacologicnoandnoParenteralnoThe
rapies

,3. Anonursingnostudentnoasksnoanonursenoaboutnopharmaceuticalnoresearchnoandnowantsnotonoknow
nothenopurposenoofnorandomizationnoinnodrugnotrials.noThenonursenoexplainsnothatnorandomiza
tionnoisnousednoto:
a. ensurenothatnodifferencesnoinnooutcomesnoarenothenoresultnoofnotreatmentnoandnonotnodi
fferencesnoinnosubjects.
b. comparenothenooutcomenocausednobynothenotreatmentnotonothenooutcomenocausednobynononotreatme
nt.

, TestnoBanknoLehne'snoPharmacologynofornoNursingnoCare,no11thn
oEditionnobynoJacquelinenoBurchum,noLauranoRosenthalnoChapte

rno1-no112|CompletenoGuidenoA+
c. makenosurenothatnoresearchersnoarenounawarenoofnowhichnosubjectsnoarenoinnowhichnogroup.
d. preventnosubjectsnofromnoknowingnowhichnogroupnotheynoarenoinnoandnopreventnopre
conceptionnobias.
ANS:noA
Randomizationnohelpsnopreventnoallocationnobias,nowhichnocannooccurnowhennoresearchersnoplac
enosubjectsnowithnodesirednocharacteristicsnoinnothenostudynogroupnoandnoothernosubjectsnoinnoth
enocontrolnogroupnosonothatnodifferencesnoinnooutcomenoarenoactuallynothenoresultnoofnodifferenc
esnoinnosubjectsnoandnonotnotreatment.
Comparingnotreatmentnooutcomenotonononotreatmentnooutcomenoisnothenodefinitionnoofnoanocontr
ollednostudy.noThenolastnotwonooptionsnodescribenothenousenoofnoblindingnoinnostudies;noblinding
noensuresnothatnoresearchersnoornosubjectsno(ornoboth)noarenounawarenoofnowhichnosubjectsnoaren
oinnowhichnogroupnosonothatnopreconceptionsnoaboutnobenefitsnoandnorisksnocannotnobiasnothenor
esults.

DIF:noCognitivenoLevel:noComprehension
REF:noThenoRandomizednoDrugno
TrialnoTOP:noNursingnoProcess:noImplementation
MSC:noNCLEXnoClientnoNeedsnoCategory:noPhysiologicnoIntegrity:noPharmacologicnoandnoParenteralnoThe
rapies

4. Someonenoasksnoanonursenoaboutnoanonewnodrugnothatnoisnoinnopreclinicalnotestingnoandnowantsno
tonoknownowhynoitnocannotnobenousednotonotreatnoanofriend‘snoillness.noWhichnostatementnobyno
thenonursenoisnocorrect?
a. ―Anodrugnoatnothisnostagenoofnodevelopmentnocannobenousednoonlynoinnopatientsnowithnoseriousn
odisease.‖
b. ―Atnothisnostagenoofnodrugnodevelopment,nothenosafetynoandnousefulnessnoofnotheno
medicationnoisnounknown.‖
c. ―Clinicalnotrialsnomustnobenocompletednotonomakenosurenothenodrugnoisnosafenotonousenoinnohum
ans.‖
d. ―Untilnopostmarketingnosurveillancenodatanoarenoavailable,nothenodrugnocannotnobenoused.‖
ANS:noB
Preclinicalnotestingnomustnobenocompletednobeforenodrugsnocannobenotestednoinnohumans.noInno
thisnostage,nodrugsnoarenoevaluatednofornotoxicities,nopharmacokineticnoproperties,noandnopote
ntiallynousefulnoeffects.noSomenodrugsnocannobenousednoinnopatientsnobeforenocompletionnoofno
PhasenoIIInostudies,nobutnothisnoisnoafternopreclinicalnotestingnoisnocomplete.noClinicalnotrialsnop
roceednoinnostages,noandnoeachnostagenohasnoguidelinesnodefiningnohownoanonewnodrugnomaynob
enousednoandnowhichnopatientsnomaynoreceivenoit.noPostmarketingnosurveillancenotakesnoplacen
oafternoanodrugnoisnoinnogeneralnouse.


DIF:noCognitivenoLevel:noComprehension
REF:noLandmarknoDrugnoLegislationno|noStagesnoofnoDrugnoDevelop
mentnoTOP:noNursingnoProcess:noImplementation
MSC:noNCLEXnoClientnoNeedsnoCategory:noPhysiologicnoIntegrity:noReductionnoofnoRisknoPotential

5. AnopatientnoasksnoanonursenowhynodrugsnothatnohavenobeennoapprovednobynothenoFDAnostilln